Official Journal of Research Center for Gastroenterology and Liver Diseases
Authors
Chronic hepatitis C (CHC) is a global infection. In Saudi Arabia, the prevalence of CHC is declining due to the implementation of a blood screening program. However, CHC still remains a leading cause of liver cirrhosis and hepatocellular carcinoma.
This is a retrospective study of CHC patients at the King Abdul Aziz University Hospital, Jeddah, Saudi Arabia.
Out of a total of 291 CHC patients from the hepatology clinic at King Abdul Aziz University hospital, Jeddah, 279 patients were included in the present study. They were primarily male (152, 54.5%), with a mean age of 50.41 1.72 years. The majority of patients were either Saudi (108, 38.7%) or Egyptian (60, 21.5%). A total of 61 patients received combination treatment with pegylated interferon and ribavirin, and one patient with sickle-cell anemia received pegylated INF monotherapy. Demographic, clinical and laboratory features of the CHC patients, and their responses to treatment were studied.
Decompensated cirrhosis was documented in 60 patients (21.5%), and hepatocellular carcinoma in 14 (5%). The mean level of serum alanine aminotransferase was 83.6 231 u/L. The predominant genotype among the 70 patients tested, was genotype 4, followed by genotype 1 (39 and 18 patients, respectively). The sustained viral response (SVR) rate was 82.99%. The main predictive factors for SVR were baseline HCV viral load and rapid virologic response (RVR). The mean duration of follow-up was 4.2 .85 years. There were 24 patients who had liver disease-related mortality.
our data showed that 22% of CHC patients progress to cirrhosis and another 22% had treatment. Liver related mortality was more common in patients with advanced cirrhosis.
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Alswat KA, Sanai FM, Altuwaijri M, Albenmousa A, Almadi M, et al. Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population. Hepat Mon. 2013;13(5):e7612. doi: https://doi.org/10.5812/hepatmon.7612
Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, et al. Distribution of Hepatitis C Virus Genotypes among Azerbaijani Patients in Capital City of Iran-Tehran. Hepat Mon. 2013;13(9):e13699. doi: https://doi.org/10.5812/hepatmon.13699
Bakhshipour A, Sargolzaie N, Kiani M, Barazesh F. Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013). Int J Infect. 2016;3(2):e34666. doi: https://doi.org/10.5812/iji.14747
Nazer MR, Beiranvand B, Obeidavi Z, Beiki O. Prevalence of hepatitis C genotypes in patients with hepatitis C in Lorestan province (2009-2013). J Kermanshah Univ Med Sci. 2014;18(2):e74169. doi: https://doi.org/10.22110/jkums.v18i2.1358
Ebrahimzadeh P, Haghshenas M, Babamahmoodi F. The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, Iran. Jundishapur J Microbiol. 2017;10(4):e40750. doi: https://doi.org/10.5812/jjm.40750
Last Update: 0 months ago
Last Update: 0 months ago
Last Update: 0 months ago
Last Update: 2 days ago